High-dose Growth Hormone (GH) Treatment In Prepubertal ... - PubMed
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Wiley Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- Publication types
- MeSH terms
- Substances
- LinkOut - more resources
Abstract
Two clinical studies were conducted to determine the effect of different doses of growth hormone (GH) on prepubertal growth in GH-deficient boys. In one study, GH doses of 1.0 and 1.5 IU/kg/week (0.33 and 0.5 mg/kg/week) were given to groups of five children and compared with a conventional Japanese dose of 0.5 IU/kg/week (0.17 mg/kg/week) in 15 children. A significant dose-dependent increase in height velocity occurred in the first year of treatment, but differences between doses were not significant thereafter. In a second study, GH was administered to ten boys at a dose of 0.5 IU/kg/week for the first year, 0.75 IU/kg/week for the second year, 1.0 IU/kg/week for the third year and 0.5 IU/kg/week for the fourth and subsequent years (0.17, 0.25, 0.33 and 0.17 mg/kg/week, respectively). During the second and third years of GH treatment, these boys had significantly higher growth rates than controls, who were given GH at 0.5 IU/kg/week (0.17 mg/kg/week) throughout, indicating successful reduction in 'waning' of the treatment effect. At the end of the fourth year, the different protocols from the two studies had both resulted in a greater height SDS than the controls, and did not advance bone maturation. In conclusion, these protocols may be effective in increasing prepubertal height gain in children with GH deficiency.
PubMed Disclaimer
Publication types
- Clinical Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Comparative Study Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Controlled Clinical Trial Actions
- Search in PubMed
- Search in MeSH
- Add to Search
MeSH terms
- Analysis of Variance Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Body Height / drug effects* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Child Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Child, Preschool Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Dose-Response Relationship, Drug Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Drug Administration Schedule Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Growth Disorders / drug therapy* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Human Growth Hormone / administration & dosage* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Human Growth Hormone / deficiency* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Japan Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Male Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Puberty / physiology Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Reference Values Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Treatment Outcome Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- Human Growth Hormone Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information
Wiley [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » Gh Ui Mg
-
Thiếu Hormone Tăng Trưởng ở Trẻ Em - Phiên Bản Dành Cho Chuyên Gia
-
Conversor De Unidades Internacionais V. 3.2.4 - MY PHARMA TOOLS
-
[PDF] 3UI = 1mg 1UI = 0,333mg - Pfizer
-
Effect Of Growth Hormone (GH) During Puberty In GH-deficient Children
-
Growth Hormone - Wikipedia
-
Converting Between IU And Mg/mcg
-
Dosing & Pen Selection | HCP | Humatrope® (somatropin) For Injection
-
3 Công Khai - Trường Đại Học Hải Dương
-
Norditropin NordiFlex 15 Mg/1.5 Ml - Patient Information Leaflet (PIL)
-
Guidelines For Growth Hormone And Insulin-Like Growth Factor-I ...